Announcements Trials
Browse Landscape

Phase

Phase 3 5

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Conditions

Colitis, Ulcerative 5

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × etrolizumab × Clear all
NCT02136069 2021-12-03

GARDENIA

Hoffmann-La Roche

Phase 3 Completed
397 enrolled 32 charts

Colitis, Ulcerative

NCT02165215 2021-08-19

LAUREL

Hoffmann-La Roche

Phase 3 Completed
359 enrolled 34 charts

Colitis, Ulcerative

NCT02100696 2021-08-13

HICKORY

Hoffmann-La Roche

Phase 3 Completed
609 enrolled 52 charts

Colitis, Ulcerative

NCT02163759 2021-07-23

HIBISCUS I

Hoffmann-La Roche

Phase 3 Completed
358 enrolled 42 charts

Colitis, Ulcerative

NCT02171429 2021-07-23

HIBISCUS II

Hoffmann-La Roche

Phase 3 Completed
358 enrolled 38 charts

Colitis, Ulcerative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡